Science Explorer Interactive view Map
Company · Lebanon · United States

Adimab (United States)

Research works
54
▲ 6% vs 2013–17
Citations
3k
56.6 per fractional work
Top-10% rate
47.9%
record average 16.5%
Open access
68%
world 28%

Not ranked overall: Adimab (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.44× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.97× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 12.32× its world share, 2 worksImmunology and Micro…Neuroscience: 0.29× its world share, 0 worksNeuroscienceEnvironmental Science: 0.04× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.19× its world share, 0 worksMaterials ScienceMedicine: 3.28× its world share, 9 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 12.3×. Every wedge is a field page.

Who are the top researchers at Adimab (United States)?

Ranked on the composite score, Tushar Jain lead among researchers whose main affiliation is Adimab (United States).

  1. 1 Tushar Jain United States · #938,382 worldwide 77 citations · 16 works
All ranked researchers at Adimab (United States)

Which keywords describe research at Adimab (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Antibody Engineering, Fc Receptors, Biopharmaceuticals, Immunogenicity and Recombinant Proteins.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Monoclonal Antibodies18▲ 237×3 topics
  2. Therapeutic Antibodies17▲ 246×2 topics
  3. Glycosylation15▲ 127×3 topics
  4. Antibody Engineering11▲ 208×1 topic
  5. Fc Receptors11▲ 208×1 topic
  6. Biopharmaceuticals8▲ 211×3 topics
  7. Immunogenicity7▲ 257×2 topics
  8. Recombinant Proteins6▲ 226×2 topics
  9. Cancer Immunotherapy6▲ 80×3 topics
  10. Protein Aggregation6▲ 137×1 topic
  11. Stability6▲ 56×1 topic
  12. CAR T Cells5▲ 221×1 topic
  13. Chimeric Antigen Receptor5▲ 221×1 topic
  14. Immunotherapy5▲ 15×2 topics
  15. Tumor Regression5▲ 112×2 topics
  16. Epidemiology5▲ 2.3×16 topics
  17. Monoclonal Antibody3▲ 82×2 topics
  18. Vaccine3▲ 14×5 topics
  19. Pathogenesis3▲ 9.7×6 topics
  20. Antigen Presentation3▲ 53×2 topics
  21. Mammalian Cells2▲ 107×1 topic
  22. Recombinant Protein2▲ 107×1 topic
  23. Cancer2▲ 3.0×4 topics
  24. Epitope Prediction2▲ 209×1 topic
  25. Peptide-MHC Binding2▲ 209×1 topic
  26. Immunity2▲ 11×3 topics
  27. Pandemic2▲ 8.2×3 topics
  28. Immune Response2▲ 5.8×6 topics
  29. ACE2 Receptor2▲ 28×2 topics
  30. Coronavirus2▲ 28×2 topics
  31. SARS-CoV-22▲ 22×2 topics
  32. Glycans2▲ 37×1 topic
  33. Immune System2▲ 9.2×1 topic
  34. Clinical Outcomes1▲ 13×2 topics
  35. Bioanalytical Methods1▲ 158×1 topic
  36. Biosimilars1▲ 158×1 topic
  37. antibody1▲ 52×1 topic
  38. spike protein1▲ 52×1 topic
  39. Health Care Utilization1▲ 15×2 topics
  40. Vaccine Development1▲ 6.8×3 topics

Which research topics does Adimab (United States) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, vaccines and immunoinformatics approaches and Protein purification and stability.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 4 works
  2. 2 CAR-T cell therapy research Oncology 3 works
  3. 3 vaccines and immunoinformatics approaches Molecular Biology 1 works
  4. 4 Protein purification and stability Molecular Biology 1 works
  5. 5 Glycosylation and Glycoproteins Research Molecular Biology 1 works
  6. 6 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
  7. 7 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  8. 8 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  9. 9 Galectins and Cancer Biology Immunology 0 works
  10. 10 Biosimilars and Bioanalytical Methods Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available68.2%not open31.8%

World: 28% of research is openly available.

with international co-authors18.8%domestic only81.2%

World: 19% is written across borders.

How has Adimab (United States)'s research output changed?

Output in 2018–2022 was 6% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lebanon

All research institutions in Lebanon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.